Stay updated on Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This signals a minor update to the page version rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-06-28T04:59:53.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate enrollment is closed, with the addition of guidance sections for reading the study record and joining a study; the page also shows an updated Intervention/Treatment header and a new revision note (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-13T17:33:24.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.4 to v3.5.5, indicating a small patch or update to the page's software or rendering. The overall content and purpose of the study page appear unchanged.
    Difference
    0.1%
    Check dated 2026-06-06T13:57:24.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study record shows a new revision version (v3.5.4) replacing the previous v3.5.3. This indicates a backend or documentation update, and no study details appear to be altered.
    Difference
    0.1%
    Check dated 2026-05-15T23:52:26.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The site footer revision number was updated from v3.5.2 to v3.5.3, indicating a website/version refresh without changing the trial details.
    Difference
    0.1%
    Check dated 2026-04-24T16:52:21.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:38:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.